Long-term Tolvaptan Treatment of Autosomal Dominant Polycystic Kidney Disease in Korea

A 22-year-old male patient was diagnosed with autosomal dominant polycystic kidney disease (ADPKD). He received conservative treatment with an angiotensin-converting enzyme inhibitor. Two years later, oral therapy, consisting of 60 mg tolvaptan per day, was initiated. Compared with height-adjusted t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ha Yeon, Lee, Seung Jin, Kim, Byung Ki, Kim, Minah, Bae, Eun Hui, Ma, Seong Kwon, Kim, Soo Wan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Electrolyte Metabolism 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414314/
https://www.ncbi.nlm.nih.gov/pubmed/30899311
http://dx.doi.org/10.5049/EBP.2018.16.2.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414314/
https://www.ncbi.nlm.nih.gov/pubmed/30899311
http://dx.doi.org/10.5049/EBP.2018.16.2.23

Ejemplares similares